Purposeful innovation. Empowered care.
Philips at EuroPCR 2023 16-19 May, Palais des Congrès, Paris.
We look forward to connecting with you online or at our Philips booth.
To empower better heart care, Philips uniquely innovates and integrates imaging, devices, software, informatics and services
Join our symposium - 60 minutes
17 May | 12:15 -13:15 CEST | Room 252B
Ultra-low contrast PCI - an indispensable toolset in complex coronary interventions and higher-risk patients
Moderator : Roberto Garbo
Anchorperson: Dariusz Dudek
Speakers: Nieves Gonzalo, Javier Escaned, Ajay J Kirtane
Join our case in point - 45 minutes
16 May | 13:45-14:30 CEST | Studio A
Physiologic guidance and optimisation in multivessel disease
Moderator : Rasha Al-Lamee
Anchorperson: Nieves Gonzalo
Speakers: Matthias Götberg, Javier Escaned, Eric Van Belle
Training village
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
Simulation learning room
Discover our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
OmniWire
World’s first solid core pressure guide wire. With an all-new workhorse design, only Philips OmniWire pressure guide wire combines confidence in wire performance with proven iFR outcomes and iFR Co-registration, making it easy to benefit from physiology throughout the case.
IntraSight Mobile
IntraSight Mobile is an easy-to-use, small footprint, IVUS imaging and physiology system, designed for coronary and peripheral vascular procedures, operable directly from the sterile field.
Philips Laser System
The Philips Laser System allows customers to utilise the proven technology of 308 nm UV light with the large variety of Philips laser catheters for coronary, peripheral vascular and heart rhythm management procedures, in a slimmer, more maneuverable and user-friendly design that is ready at the turn of a key to treat patients as the physicians see fit.
Ultra-low contrast PCI
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
Dynamic Coronary Roadmap
Dynamic Coronary Roadmap, a Philips-exclusive technology, creates a motion-compensated, real-time view of coronary arteries. A highlighted coronary angiogram is superimposed on a live 2D fluoroscopic image, creating a colored roadmap that adjusts automatically, providing continuous visual feedback on positioning of wires and catheters.
Hemo with IntelliVue X3
Philips Interventional Hemodynamic system (Hemo system) brings advanced hemodynamic measurements to the cath lab to support clinical decision making. Integrated with the state-of-the-art IntelliVue X3 patient monitor and Azurion, this system helps further simplify your cath lab workflow.
Continuous monitoring
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Enter our cardiology virtual space
Explore all the latest Philips cardiology innovations including our informatics solutions which bring meaningful data together across the cardiovascular care continuum.
Clinical solutions
iFR Co-registration
IVUS guidance
Coronary diagnostic for Complex PCI
IntelliSpace Cardiovascular
@PhilipsLiveFrom
Our PR Contacts
Joost Maltha Joost.maltha@philips.com Philips Global Press Office Tel: +31 6 10 55 8116
References:
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
